Journey Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	57.79	55.13	59.66	71	63.13	44.53
Other Revenue	1.61	1	19.52	2.67	-	-
Revenue	59.4	56.13	79.18	73.67	63.13	44.53
Revenue Growth (YoY)	2.82%	-29.11%	7.48%	16.69%	41.77%	27.52%
Cost of Revenue	20.16	20.88	22.89	30.78	25.58	14.59
Gross Profit	39.24	35.26	56.29	42.89	37.55	29.94
Selling, General & Admin	44.57	40.2	43.91	59.47	39.83	22.09
Research & Development	0.54	9.86	7.54	10.94	16.56	-
Amortization of Goodwill & Intangibles	4.17	3.42	3.77	-	-	-
Other Operating Expenses	-4.55	-4.55	-	-	-	-
Operating Expenses	44.73	48.93	55.22	70.41	56.39	22.09
Operating Income	-5.5	-13.68	1.07	-27.52	-18.84	7.85
Interest Expense	-3.6	-2.7	-1.7	-2.02	-7.03	-0.7
Interest & Investment Income	0.63	0.76	0.32	0.06	0	-
Currency Exchange Gain (Loss)	-0.08	-0.12	-0.18	-0.09	-	-
Other Non Operating Income (Expenses)	-	-	-	-	-0.45	-
EBT Excluding Unusual Items	-8.54	-15.74	-0.49	-29.57	-26.32	7.15
Merger & Restructuring Charges	-	-	-	-	-6.5	-
Asset Writedown	-	-	-3.14	-	-	-
Other Unusual Items	-	1.13	-	-	-9.54	-
Pretax Income	-8.54	-14.61	-3.63	-29.57	-42.36	7.15
Income Tax Expense	0.12	0.06	0.22	0.06	1.63	1.87
Net Income	-8.66	-14.67	-3.85	-29.63	-43.99	5.28
Net Income to Common	-8.66	-14.67	-3.85	-29.63	-43.99	5.28
Net Income Growth	-	-	-	-	-	45.74%
Shares Outstanding (Basic)	23	20	18	18	10	9
Shares Outstanding (Diluted)	23	20	18	18	10	11
Shares Change (YoY)	16.55%	12.06%	4.00%	72.05%	-5.96%	7.55%
EPS (Basic)	-0.38	-0.72	-0.21	-1.69	-4.32	0.58
EPS (Diluted)	-0.38	-0.72	-0.21	-1.69	-4.32	0.49
EPS Growth	-	-	-	-	-	36.11%
Free Cash Flow	-3.93	-9.13	5.24	-13.53	-2.18	5.13
Free Cash Flow Per Share	-0.17	-0.45	0.29	-0.77	-0.21	0.47
Gross Margin	66.05%	62.80%	71.09%	58.23%	59.48%	67.23%
Operating Margin	-9.25%	-24.37%	1.35%	-37.35%	-29.84%	17.63%
Profit Margin	-14.58%	-26.14%	-4.87%	-40.22%	-69.68%	11.86%
Free Cash Flow Margin	-6.62%	-16.26%	6.62%	-18.37%	-3.45%	11.53%
EBITDA	-1.32	-10.25	4.84	-23.24	-16.37	9.28
EBITDA Margin	-2.22%	-18.27%	6.11%	-31.55%	-25.92%	20.83%
D&A For EBITDA	4.17	3.42	3.77	4.28	2.47	1.43
EBIT	-5.5	-13.68	1.07	-27.52	-18.84	7.85
EBIT Margin	-9.25%	-24.37%	1.35%	-37.35%	-29.84%	17.63%
Effective Tax Rate	-	-	-	-	-	26.14%
Revenue as Reported	59.4	56.13	79.18	73.67	63.13	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q